Prof Martin Glennie, Director of Cancer Sciences, University of Southampton, UK
With eight antibodies approved for cancer treatment , Prof Glennie discusses the future of antibody research; antibody combinations with vaccines; why only some patients respond; and the new programme looking at antibodies that promote an immune response in neuroblastoma patients.